Dual targeting could enhance the effect, particularlyin the context of applications targeting tissues where both chemerinreceptors are expressed, such as in skin tissues for psoriasis patients.In this study, we have combined SAR, receptor mutagenesis, and molecularmodeling to clarify the binding mode of an antagonist at the chemerinreceptor. Here, CMKLR1 is linked to psoriasis.